Join to View Full Profile
130 Town Center DriveSuite 101Troy, MI 48084
Phone+1 248-740-0670
Dr. Kernen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Corewell Health William Beaumont University HospitalResidency, Urology, 1995 - 1999- Corewell Health East Beaumont (Royal Oak)Residency, Surgery, 1993 - 1995
Wayne State University School of MedicineClass of 1993
Certifications & Licensure
MI State Medical License 2000 - 2028
American Board of Urology Urology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Top MD Consumers Checkbook
Clinical Trials
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jan 01
- TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer Start of enrollment: 2021 May 05
Publications & Presentations
PubMed
- Temporarily implanted nitinol device versus prostatic urethral lift for minimally invasive surgical treatment of benign prostatic hyperplasia with lower urinary tract ...Kenneth M Kernen, Shalina Omar, Bradley Goodnight, Paul Skodny, Stuart Bruce
The Canadian Journal of Urology. 2023-10-01 - 4 citationsReal-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients With Non-Metastatic Castration-Resistant Prostate Cancer.Benjamin Lowentritt, Gordon Brown, Dominic Pilon, Lorie Ellis, Guillaume Germain
Urology. 2022-08-01 - 1 citationsEvaluation of an RNAseq-Based Immunogenomic Liquid Biopsy Approach in Early-Stage Prostate CancerLeander Van Neste, Kirk J. Wojno, Ricardo Henao, Shrikant Mane, Howard J. Korman
Cells. 2021-09-28
Press Mentions
Tavanta Therapeutics Announces Completion of Enrollment in Pivotal Phase 3 Trial of TAVT-45 for the Treatment of Metastatic Prostate CancerAugust 1st, 2022- Temporary Implant Provides Relief for Men with Enlarged ProstateOctober 19th, 2021
- iTind System for BPH Treatment Reaches Two Major Milestones: First Commercial Treatments and CMS Reimbursement Code AssignedNovember 17th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
